High throughput screening aids clinical decision-making in refractory acute myeloid leukaemia.
Jessop SJ, Fuentos-Bolanos N, Mayoh C, Dolman MEM, Tax G, Wong-Erasmus M, Ajuyah P, Tyrell V, Marshall GM, Ziegler DS, Lau LMS.
Jessop SJ, et al. Among authors: ziegler ds.
Cancer Rep (Hoboken). 2024 Apr;7(4):e2061. doi: 10.1002/cnr2.2061.
Cancer Rep (Hoboken). 2024.
PMID: 38662349
Free PMC article.